Bay Street News

Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial

February 25, 2019
- TSX Venture News
  0
ShareTweet
ShareTweet
» View More News for February 25, 2019

Tweets by baystnews

© 2020 BayStNews.com - All Rights Reserved
  • Home
  • TSX News
  • TSX Venture News
  • NASDAQ Companies
  • NYSE Companies
  • Canadian Stock Exchange News
  • Pink Sheets News
  • OTCBB News
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search